Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers

Bioorg Med Chem. 2012 Jun 15;20(12):3828-36. doi: 10.1016/j.bmc.2012.04.034. Epub 2012 May 2.

Abstract

Two desferrioxamine B-ciprofloxacin conjugates with 'trimethyl-lock' based linkers that are designed to release the antibiotic after esterase or phosphatase-mediated hydrolysis were synthesized. The potential esterase-sensitive conjugate 13 displayed moderate to good antibacterial activities against selected ferrioxamine-utilizing bacteria, although the activities were lower than the parent drug ciprofloxacin. However, the potential phophatase-sensitive conjugate 23 was inactive against the same panel of organisms tested. These properties appeared to be related to the activating efficiency of the linker by the enzyme and to the outer membrane protein recognition of the chemically modified siderophore used in the conjugate.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anti-Bacterial Agents / chemical synthesis*
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Ciprofloxacin / chemistry
  • Ciprofloxacin / metabolism*
  • Ciprofloxacin / pharmacology
  • Deferoxamine / chemistry
  • Deferoxamine / metabolism*
  • Deferoxamine / pharmacology
  • Drug Delivery Systems*
  • Esterases / metabolism*
  • Gram-Negative Bacteria / drug effects
  • Gram-Positive Bacteria / drug effects
  • Hydrolysis
  • Microbial Sensitivity Tests
  • Phosphoric Monoester Hydrolases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • Esterases
  • Phosphoric Monoester Hydrolases
  • Deferoxamine